CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Vietnam

Publisher Name:
Published Date: 1-Jun-2014
No. of pages: 194

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Vietnam”. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

In 2013, Vietnam’s population stood at 89.7 million, an increase from 85.1 million in 2008 due to the high birth rate and low mortality rate. The country’s pharmaceutical market was estimated to have been worth $2.9 billion in 2013 and is expected to reach $8 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 15.4%. According to an EU Economic and Commercial Counsellor (EUECC) report in 2011, Vietnam’s medical device market was estimated at approximately $220m in 2010 and is expected to grow at a CAGR of 10% to over $350m by 2015.

The positive trends in Vietnam’s healthcare market can primarily be attributed to -

  • Increasing coverage of healthcare insurance
  • Government initiatives to improve healthcare facilities

Scope

This report provides information on the healthcare, regulatory, and reimbursement landscape in the Vietnam, including the following -

  • Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, GlaxoSmithKline, AstraZeneca, Novartis and DHG Pharmaceutical JSC
  • An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

The report will enhance your decision-making capability by allowing you to -

  • Develop business strategies through an understanding of the trends shaping and driving the healthcare market
  • Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market

Table of Contents For This Report

Table of Contents

1 Table of Contents7

1.1 List of Tables 10

1.2 List of Figures 13

2 Introduction 17

2.1 GlobalData Report Guidance 17

3 Overview of the Pharmaceutical and Medical Device Markets 18

3.1 Pharmaceutical Market 18

3.1.1 Market Overview 18

3.1.2 Pharmaceutical Imports and Exports 22

3.1.3 Supply Channels 23

3.1.4 Market Segments 24

3.1.5 Overview of Major Disease Areas 29

3.1.6 Major Players 34

3.2 Medical Device Market 70

3.3 Market Drivers and Barriers 71

3.3.1 Drivers 71

3.3.2 Barriers 73

4 Market Access 75

4.1 Reimbursement and Payer Landscape 75

4.1.1 Overview of Healthcare System 75

4.1.2 Reimbursement Process 76

4.1.3 Overview of Insurance Providers 78

4.1.4 Patient Share in Healthcare Spending 83

4.1.5 Drug Price Trend 84

4.1.6 Pricing Policies 85

4.2 Regulatory Landscape 86

4.2.1 Overview of Regulatory Agencies 86

4.2.2 Market Authorization Procedure for Pharmaceutical Products 86

4.2.3 Licensing Process for Pharmaceutical Manufacturing 93

4.2.4 Licensing Process for Pharmaceutical Exports and Imports 94

4.2.5 Intellectual Property Rights 96

4.2.6 Clinical Trial Regulations 100

4.2.7 Pharmaceutical Advertising Regulations 102

4.2.8 Pharmacy Regulations 104

4.2.9 Labeling and Packaging Regulations 105

5 Country Analysis 108

5.1 Political Environment 108

5.1.1 Political Structure 108

5.1.2 Analysis of the Current Political Environment 108

5.1.3 Healthcare Policy Initiatives 110

5.2 Economic Landscape 111

5.3 Economic Indicators 114

5.3.1 Gross Domestic Product 114

5.3.2 Gross National Income 118

5.3.3 Inflation 119

5.3.4 Currency Exchange Rate 123

5.3.5 Foreign Direct Investment 124

5.3.6 Foreign Exchange Reserves 125

5.3.7 Trade Balance 126

5.3.8 Government Structural Balance 128

5.3.9 General Government Net Debt 129

5.3.10 Major Industries 130

5.4 Demographics 131

5.4.1 Population 131

5.4.2 Education and Literacy 149

5.4.3 Employment 151

5.4.4 Disease Burden 152

5.5 Healthcare Infrastructure 155

5.5.1 Healthcare Facilities 155

5.5.2 Healthcare Parameters 159

5.5.3 Environmental Health 161

5.5.4 Healthcare Personnel 165

5.5.5 Healthcare Expenditure 168

5.6 Trade Associations 171

5.6.1 Vietnam Pharmaceutical Companies Association 171

5.6.2 Vietnam General Association of Medicine and Pharmacy 171

5.6.3 Vietnam Public Health Association 172

5.7 Trade Fairs 173

6 Opportunities and Challenges 174

6.1 Opportunities 174

6.2 Challenges 175

7 Appendix 177

7.1 Abbreviations 177

7.2 Bibliography 181

7.3 Research Methodology 191

7.3.1 Coverage 191

7.3.2 Secondary Research 192

7.3.3 Forecasts 192

7.3.4 Expert Panel 192

7.4 Disclaimer 193

List of Tables

Table 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2013 20

Table 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2014-2020 21

Table 3: Pharmaceutical Market, Vietnam, Imports and Exports ($bn), 2008-2013 22

Table 4: Pharmaceutical Market, Vietnam, OTC, Major Segment Share (%), 2010 28

Table 5: Pharmaceutical Market, Vietnam, Major Disease Areas, Number of Cancer Cases, 2010 31

Table 6: Pharmaceutical Market, Vietnam, Major Disease Areas, Prevalence and Number of Mental Disorder Cases, 2005 32

Table 7: Pharmaceutical Market, Sanofi, Global, Major Products, Revenue ($bn), 2013 35

Table 8: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014 36

Table 9: Pharmaceutical Market, GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 41

Table 10: Pharmaceutical Market, Global, Late-Stage Pipeline, GlaxoSmithKline, 2014 42

Table 11: Pharmaceutical Market, AstraZeneca, Global, Major Products by Therapy Area, Revenue, 2013 50

Table 12: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014 51

Table 13: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 58

Table 14: Pharmaceutical Market, Global, Planned Filings, Novartis, 2014-2018 59

Table 15: Pharmaceutical Market, DHG Pharmaceutical JSC, Global, Major Products, 2014 68

Table 16: Overview of Insurance Providers, Vietnam, Health Insurance Population Coverage (%), 2008-2013 82

Table 17: Overview of Insurance Providers, Vietnam, Health Insurance Population Coverage (million), 2008-2013 83

Table 18: Overview of Insurance Providers, Vietnam, Patient Share of Healthcare Expenditure (%), 2008-2013 84

Table 19: Healthcare Spending, Vietnam, Price Change (%), 2008-2012 85

Table 20: Regulatory Landscape, Vietnam, List of the Generic Drugs Required to Submit BE/BA at the Time of Approval, 2014 91

Table 21: Regulatory Landscape, Vietnam, Patent Filing Fees and Charges, 2014 99

Table 22: Regulatory Landscape, Vietnam, Trademark Filing Fees and Charges, 2014 99

Table 23: Regulatory Landscape, Vietnam, Labeling Guidelines, 2014 106

Table 24: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2013 114

Table 25: Economic Indicators, Vietnam, Forecast GDP per Capita ($), 2014-2020 115

Table 26: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2013 116

Table 27: Economic Indicators, Vietnam, Forecast GDP Annual Growth (%), 2014-2020 117

Table 28: Economic Indicators, Vietnam, GNI per Capita ($), 2008-2013 118

Table 29: Economic Indicators, Vietnam, Average Consumer Price Index, 2008-2013 119

Table 30: Economic Indicators, Vietnam, Average Consumer Price Index, Forecast, 2014-2020 120

Table 31: Economic Indicators, Vietnam, Average Consumer Price Index Annual Change (%), 2008-2013 121

Table 32: Economic Indicators, Vietnam, Average Consumer Price Index Annual Change (%), Forecast, 2014-2020 122

Table 33: Economic Indicators, Vietnam, Currency Exchange Rate (VND/$), 2008-2013 123

Table 34: Economic Indicators, Vietnam, Foreign Direct Investment ($bn), 2008-2013 124

Table 35: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2013 125

Table 36: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2013 126

Table 37: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2013 127

Table 38: Economic Indicators, Vietnam, General Government Structural Balance ($bn), 2008-2013 128

Table 39: Economic Indicators, Vietnam, General Government Net Debt (% of GDP), 2008-2013 129

Table 40: Economic Indicators, Vietnam, Major Industries, Turnover ($bn), 2011, 2012 130

Table 41: Demographics, Vietnam, Population (million), 2008-2013 131

Table 42: Demographics, Vietnam, Forecast Population (million), 2014-2020 132

Table 43: Demographics, Vietnam, Urban and Rural Population Share (%), 2008-2013 133

Table 44: Demographics, Vietnam, Forecast Urban and Rural Population Share (%), 2014-2020 134

Table 45: Demographics, Vietnam, Distribution by Age Group (%), 2008-2013 135

Table 46: Demographics, Vietnam, Forecast Distribution by Age Group (%), 2014-2020 136

Table 47: Demographics, Vietnam, Births (per 1,000 Population), 2008-2013 138

Table 48: Demographics, Vietnam, Mortality (per 1,000 Population), 2008-2013 139

Table 49: Demographics, Vietnam, Major Causes of Mortality (‘000), 2008 140

Table 50: Demographics, Vietnam, Children Table 51: Demographics, Vietnam, Immunization Rate (%), 2008-2013 142

Table 52: Demographics, Vietnam, Major Causes of Male Mortality (‘000), 2008 144

Table 53: Demographics, Vietnam, Major Causes of Female Mortality (‘000), 2008 145

Table 54: Demographics, Vietnam, Gender Ratio (M/F), 2008-2013 146

Table 55: Demographics, Vietnam, Life Expectancy at Birth (Years), 2008-2013 147

Table 56: Demographics, Vietnam, Forecast Life Expectancy at Birth (Years), 2014-2020 148

Table 57: Demographics, Vietnam, Gross Enrollment (%), 2008-2013 150

Table 58: Demographics, Vietnam, Unemployment (%), 2008-2013 151

Table 59: Demographics, Vietnam, Major Disease Prevalence (%), 2012 153

Table 60: Demographics, Vietnam, DALY (per 100,000 Population), 2004 154

Table 61: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2013 157

Table 62: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2013 158

Table 63: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 Population), 2008-2013 160

Table 64: Healthcare Infrastructure, Vietnam, Practicing Physicians (per 1,000 Population), 2008-2013 161

Table 65: Environmental Health, Vietnam, PM10 (µg/m3), 2008-2013 162

Table 66: Environmental Health, Vietnam, CO2 Emissions (million tons), 2008-2013 163

Table 67: Healthcare Personnel, Vietnam, Nurses (per 100,000 Population), 2008-2013 166

Table 68: Healthcare Personnel, Vietnam, Midwives (per 100,000 Population), 2008-2013 166

Table 69: Healthcare Personnel, Vietnam, Pharmacists (per 100,000 Population), 2008-2013 167

Table 70: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2013 168

Table 71: Healthcare Expenditure, Vietnam, Share of Major Components (%), 2007 169

Table 72: Healthcare Expenditure, Vietnam, Public-Private Share (%), 2008-2013 170

Table 73: Trade Fairs, Vietnam, Major Healthcare Trade Fairs, 2014 173

List of Figures

Figure 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2013 20

Figure 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2014-2020 21

Figure 3: Pharmaceutical Market, Vietnam, Imports and Exports ($bn), 2008-2013 22

Figure 4: Pharmaceutical Market, Vietnam, Distribution Chain, 2014 23

Figure 5: Pharmaceutical Market, Vietnam, OTC, Major Segment Share (%), 2010 28

Figure 6: Healthcare Market, Indonesia, Drivers and Barriers, 2014 74

Figure 7: Market Access, Vietnam, Healthcare System, 2014 76

Figure 8: Overview of Insurance Providers, Vietnam, Funding to Healthcare System, 2014 80

Figure 9: Overview of Insurance Providers, Vietnam, Health Insurance Population Coverage (%), 2008-2013 81

Figure 10: Overview of Insurance Providers, Vietnam, Health Insurance Population Coverage (million), 2008-2013 82

Figure 11: Overview of Insurance Providers, Vietnam, Patient Share of Healthcare Expenditure (%), 2008-2013 83

Figure 12: Healthcare Spending, Vietnam, Price Change (%), 2008-2012 84

Figure 13: Regulatory Landscape, Vietnam, New Drug Approval Process, 2014 90

Figure 14: Regulatory Landscape, Vietnam, Generic Drug Approval Process, 2014 93

Figure 15: Regulatory Landscape, Vietnam, Patent and Trademark Approval Process, 2014 100

Figure 16: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2013 114

Figure 17: Economic Indicators, Vietnam, Forecast GDP per Capita ($), 2014-2020 115

Figure 18: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2013 116

Figure 19: Economic Indicators, Vietnam, Forecast GDP Annual Growth (%), 2014-2020 117

Figure 20: Economic Indicators, Vietnam, GNI per Capita ($), 2008-2013 118

Figure 21: Economic Indicators, Vietnam, Average Consumer Price Index, 2008-2013 119

Figure 22: Economic Indicators, Vietnam, Average Consumer Price Index, Forecast, 2014-2020 120

Figure 23: Economic Indicators, Vietnam, Average Consumer Price Index Annual Change (%), 2008-2013 121

Figure 24: Economic Indicators, Vietnam, Average Consumer Price Index Annual Change (%), Forecast, 2014-2020 122

Figure 25: Economic Indicators, Vietnam, Currency Exchange Rate (VND/$), 2008-2013 123

Figure 26: Economic Indicators, Vietnam, Foreign Direct Investment ($bn), 2008-2013 124

Figure 27: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2013 125

Figure 28: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2013 126

Figure 29: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2013 127

Figure 30: Economic Indicators, Vietnam, General Government Structural Balance ($bn), 2008-2013 128

Figure 31: Economic Indicators, Vietnam, General Government Net Debt (%), 2008-2013 129

Figure 32: Economic Indicators, Vietnam, Major Industries, Turnover ($bn), 2011 and 2012 130

Figure 33: Demographics, Vietnam, Population (million), 2008-2013 131

Figure 34: Demographics, Vietnam, Forecast Population (million), 2014-2020 132

Figure 35: Demographics, Vietnam, Urban and Rural Population Share (%), 2008-2013 133

Figure 36: Demographics, Vietnam, Forecast Urban and Rural Population Share (%), 2014-2020 134

Figure 37: Demographics, Vietnam, Distribution by Age Group (%), 2008-2013 135

Figure 38: Demographics, Vietnam, Forecast Distribution by Age Group (%), 2014-2020 136

Figure 39: Demographics, Vietnam, Births (per 1,000 Population), 2008-2013 137

Figure 40: Demographics, Vietnam, Mortality (per 1,000 Population), 2008-2013 138

Figure 41: Demographics, Vietnam, Major Causes of Mortality (‘000), 2008 139

Figure 42: Demographics, Vietnam, Children Figure 43: Demographics, Vietnam, Immunization Rate (%), 2008-2013 142

Figure 44: Demographics, Vietnam, Major Causes of Male Mortality (‘000), 2008 143

Figure 45: Demographics, Vietnam, Major Causes of Female Mortality (‘000), 2008 145

Figure 46: Demographics, Vietnam, Gender Ratio (M/F), 2008-2013 146

Figure 47: Demographics, Vietnam, Life Expectancy at Birth (Years), 2008-2013 147

Figure 48: Demographics, Vietnam, Forecast Life Expectancy at Birth (Years), 2014-2020 148

Figure 49: Demographics, Vietnam, Gross Enrollment (%), 2008-2013 150

Figure 50: Demographics, Vietnam, Unemployment (%), 2008-2013 151

Figure 51: Demographics, Vietnam, Major Diseases Prevalence (%), 2012 152

Figure 52: Demographics, Vietnam, DALY (per 100,000 Population), 2004 154

Figure 53: Healthcare Infrastructure, Vietnam, Healthcare System, 2014 156

Figure 54: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2013 157

Figure 55: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2013 158

Figure 56: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 Population), 2008-2013 159

Figure 57: Healthcare Infrastructure, Vietnam, Practicing Physicians (per 100,000 Population), 2008-2013 160

Figure 58: Environmental Health, Vietnam, PM10 (µg/m3), 2008-2013 162

Figure 59: Environmental Health, Vietnam, CO2 Emissions (million tons), 2008-2013 163

Figure 60: Healthcare Personnel, Vietnam, Nurses (per 100,000 Population), 2008-2013 165

Figure 61: Healthcare Personnel, Vietnam, Midwives (per 100,000 Population), 2008-2013 166

Figure 62: Healthcare Personnel, Vietnam, Pharmacists (per 100,000 Population), 2008-2013 167

Figure 63: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2013 168

Figure 64: Healthcare Expenditure, Vietnam, Share of Major Components (%), 2007 169

Figure 65: Healthcare Expenditure, Vietnam, Public-Private Share (%), 2008-2013 170

Figure 66: Healthcare Market, Vietnam, Opportunities and Challenges, 2014 176

Get Updates

Share This Post

Latest Reports from Life Sciences category

© 6621 MarketOptimizer.org. All rights reserved.